UIH(SH:688271) Sou Hu Cai Jing·2025-12-11 12:41Core Viewpoint - The financial performance of United Imaging Healthcare (688271) shows significant growth in revenue and net profit for the first three quarters of 2025, indicating strong operational efficiency and market demand for its medical imaging and treatment solutions [2]. Financial Performance - For the first three quarters of 2025, the company's main revenue reached 8.859 billion yuan, a year-on-year increase of 27.39% [2]. - The net profit attributable to shareholders was 1.12 billion yuan, up 66.91% year-on-year [2]. - The net profit excluding non-recurring items was 1.053 billion yuan, reflecting a substantial increase of 126.94% year-on-year [2]. - In Q3 2025 alone, the company reported a single-quarter main revenue of 2.843 billion yuan, a remarkable increase of 75.41% year-on-year [2]. - The single-quarter net profit attributable to shareholders was 122 million yuan, showing a year-on-year growth of 143.8% [2]. - The single-quarter net profit excluding non-recurring items was 87.6141 million yuan, up 126.24% year-on-year [2]. - The company's debt ratio stands at 30.08%, with investment income of 606.847 million yuan and financial expenses of -438.233 million yuan, while the gross profit margin is 47.02% [2]. Market Activity - As of December 11, 2025, the stock price of United Imaging Healthcare closed at 128.7 yuan, down 0.84% with a turnover rate of 0.31% [1]. - The trading volume was 25,700 hands, with a total transaction value of 332 million yuan [1]. - On December 11, the net outflow of main funds was 26.0505 million yuan, accounting for 7.85% of the total transaction value, while retail investors saw a net inflow of 13.9798 million yuan, representing 4.21% of the total transaction value [1]. Analyst Ratings - In the last 90 days, 25 institutions have provided ratings for the stock, with 18 giving a buy rating and 7 an overweight rating [2]. - The average target price set by institutions over the past 90 days is 17.312 billion yuan [2].